Orr Inbar

Sales & Marketing

In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.

Digital

Over 90% of experimental therapies that reach human trials fail to make it to market.

News

Just a few weeks after filing for bankruptcy protection, Sangamo has found buyers for some of its key assets, raising up to $263.5m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.